Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Bionano Genomics, Inc. - Common Stock (NQ:BNGO)

1.435 -0.065 (-4.33%)
Streaming Delayed Price Updated: 3:54 PM EST, Jan 20, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Bionano Genomics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
News headline image
Don’t Confuse Bionano Genomics As an Investment Right Now ↗
The science underlining BNGO stock is incredibly compelling. But that’s not what the market actually cares about right now. 
Via InvestorPlace
News headline image
Bionano Genomics Has Disappointed, but Its NHS Deal May Turn Things Around ↗
It's hard to reconcile the sell-off in BNGO stock with Bionano's progress in advancing the Saphyr system - but this presents an opportunity. 
Via InvestorPlace
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
Gainers Vaxart (NASDAQ:VXRT) shares moved upwards by 53.38% to $9.29 during Tuesday's regular session. Vaxart's stock is trading at a volume of 115.1 million... 
Via Benzinga
News headline image
Why Cyclerion, Sol-Gel, Aldeyra, DermTech and Bionano Genomics Are Moving Today ↗
Cyclerion Therapeutics, Inc. (NASDAQ: CYCN), Sol-Gel Technologies Ltd. (NASDAQ: SLGL), Aldeyra Therapeutics, Inc. (NASDAQ: ALDX), DermTech, Inc. (NASDAQ: DMTK) and Bionano... 
Via Benzinga
What's Going On With Bionano Genomics Stock Today? ↗
BioNano Genomics Inc (NASDAQ:BNGO) shares are trading higher by 19.5% at $7.36 Mon... 
Via Benzinga
News headline image
58 Biggest Movers From Yesterday ↗
Gainers Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) shares jumped 104.2% to close at $8.70 on Monday after the company announced the full details of its Phase 2 trial... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
Gainers Reviva Pharmaceuticals (NASDAQ:RVPH) shares rose 72.91% to $7.47 during Monday's regular session. Reviva Pharmaceuticals's stock is trading at a volume of... 
Via Benzinga
News headline image
Bionano’s UK Deal Is Huge for BNGO Stock ↗
Bionano's deal with the UK's National Health Service validates the company's Saphyr system and puts it on the road to becoming a global powerhouse 
Via InvestorPlace
Global Market For Sleep Aid Devices Could Reach $112.7 Billion By 2025
Via FinancialNewsMedia
News headline image
Is Bionano Genomics a Buy? ↗
Can you count on this company's novel gene diagnostic technology? 
Via The Motley Fool
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
Gainers Renalytix AI (NASDAQ:RNLX) stock moved upwards by 20.93% to $30.5 during Thursday's pre-market session. The market value of their outstanding shares is at $1.0... 
Via Benzinga
Topics Artificial Intelligence
News headline image
20 Stocks Moving in Thursday's Pre-Market Session ↗
Gainers Teradata Corporation (NYSE: TDC) shares rose 29% to $51.45 in pre-market trading after the company raised its Q1 earnings guidance. SeaChange International, Inc. (NYSE:... 
Via Benzinga
News headline image
2 Biopharma Stocks That Look Ready For A Bullish Reversal ↗
Ocugen Inc. (NASDAQ: OCGN) and Bionano Inc. (NASDAQ: BNGO) are two biopharma stocks moving higher Wednesday. Ocugen is moving after its partner Bharat Biotech announced... 
Via Benzinga
News headline image
Why Bionano Genomics, Ocugen Are Rallying Today ↗
Bionano Genomics, Inc. (NASDAQ: BNGO) and Ocugen, Inc. (NASDAQ: OCGN) were among the early movers among biopharma stocks. Bionano Gains On Adoption of Genomic Mapping System By U.... 
Via Benzinga
News headline image
Should You Buy Bionano Genomics in April? ↗
This stock market mover's growth story is just beginning. 
Via The Motley Fool
News headline image
Why Bionano Genomics Stock Is Tumbling Today ↗
No news; just run-of-the-mill volatility. 
Via The Motley Fool
News headline image
Bionano Genomics Stock Is Too Wild for Its Own Good ↗
BNGO stock has seen too much action without fundamental justification. It makes a better speculative bet than an investment. 
Via InvestorPlace
News headline image
Bionano Genomics Stock Has Huge Potential, But It’s Very Risky ↗
BNGO stock is a play on a potentially disruptive technology. But investors can't forget that most potentially disruptive technologies fail. 
Via InvestorPlace
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.